Patents by Inventor Hamilton D. Dickson

Hamilton D. Dickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical Compounds
    Publication number: 20220144834
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Application
    Filed: October 25, 2021
    Publication date: May 12, 2022
    Inventors: John G. CATALANO, Pek Yoke CHONG, Hamilton D. DICKSON, Martin R. LEIVERS, Jason Gordon WEATHERHEAD
  • CHEMICAL COMPOUNDS
    Publication number: 20200255428
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Application
    Filed: October 5, 2018
    Publication date: August 13, 2020
    Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: John G. CATALANO, Pek Yoke CHONG, Hamilton D. DICKSON, Martin R. LEIVERS, Jason Gordon WEATHERHEAD
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10472336
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: November 12, 2019
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Pek Yoke Chong, Martha Alicia De La Rosa, Hamilton D. Dickson, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Vincent Wing-Fai Tai
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10358427
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: July 23, 2019
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Pek Yoke Chong, Martha Alicia De La Rosa, Hamilton D. Dickson, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Vincent Wing-Fai Tai
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20190040023
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Application
    Filed: September 22, 2016
    Publication date: February 7, 2019
    Inventors: Pek Yoke CHONG, Martha Alicia DE LA ROSA, Hamilton D DICKSON, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO, Vincent Wing-Fai TAI
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20180290988
    Abstract: This invention is directed to photoluminescent compounds based on rhodamine dyes with green emission and uses thereof for photoluminescence based devices.
    Type: Application
    Filed: September 22, 2016
    Publication date: October 11, 2018
    Inventors: Pek Yoke CHONG, Martha Alicia DE LA ROSA, Hamilton D. DICKSON, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO, Vincent Wing-Fai TAI
  • Compounds And Methods For Enhancing Innate Immune Responses
    Publication number: 20140249143
    Abstract: Provided are certain compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections.
    Type: Application
    Filed: October 19, 2012
    Publication date: September 4, 2014
    Applicant: GlaxoSmithKline LLC
    Inventors: Anna Lindsey Banka, Janos Botyanszki, Eric Gregory Burroughs, John George Catalano, Wendy Huang Chern, Hamilton D. Dickson, Margaret J. Gartland, Robert Hamatake, Hans Hofland, Jesse Daniel Keicher, Christopher Brooks Moore, John Bradford Shotwell, Matthew David Tallant, Jean-Philippe Therrien, Shihyun You